FDA Adverse Event
Injury
Summary report: N
URETEX TO2 URETHRAL SUPPORT SYSTEM
MDR report key: 3213439
·
Received May 6, 2013
Report
- Report Number
- 1018233-2013-01762
- Event Type
- Injury
- Date Received
- May 6, 2013
- Report Date
- November 10, 2017
- Manufacturer
- C.R. BARD, INC. (COVINGTON) -1018233
- Product Code
- OTN
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- NY, US
- Reporter Occupation
- ATTORNEY
- Health Professional
- N
Narratives
Description of Event or Problem · 1
IT WAS REPORTED BY THE PATIENT'S ATTORNEY THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PATIENT HAS EXPERIENCED PAIN, DISABILITY AND IMPAIRMENT. ASSOCIATED MDR: 1018233-2013-01759 AND 1018233-2013-01761.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 197908 | URETEX TO2 URETHRAL SUPPORT SYSTEM | URETEX TO2 URETHRAL SUPPORT W/HOOK NEEDLE | OTN | C.R. BARD, INC. (COVINGTON) -1018233 | NA | SGC00619 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Female | Required Intervention | AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM| AVAULTA POSTERIOR BIOSYNTHETIC SUPPORT SYSTEM| AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM| AVAULTA POSTERIOR BIOSYNTHETIC SUPPORT SYSTEM |